Home/Filings/4/0001683168-22-000276
4//SEC Filing

DVONCH JEROME J 4

Accession 0001683168-22-000276

CIK 0001367083other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 8:32 PM ET

Size

5.5 KB

Accession

0001683168-22-000276

Insider Transaction Report

Form 4
Period: 2022-01-14
DVONCH JEROME J
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2022-01-14+30,00057,777 total
    Exercise: $4.60Exp: 2032-01-14Common stock (30,000 underlying)
Footnotes (2)
  • [F1]The options vest 10,000 options each on 07/14/2022, 07/14/2023, 07/14/2024 and or upon a change of control.
  • [F2]The options were awarded and granted to Mr. Dvonch for services performed.

Documents

1 file

Issuer

Sonoma Pharmaceuticals, Inc.

CIK 0001367083

Entity typeother

Related Parties

1
  • filerCIK 0001518735

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 8:32 PM ET
Size
5.5 KB